17 January 2002
Med Sci Monit 2002; 8(1): CR5-8 :: ID: 420948
BACKGROUND: D-Dimer measurement has been used as a simple, non-invasivetest to rule out thromboembolic phenomena in patients at risk for deep venous thrombosis (DVT) and /or pulmonary embolism (PE). Elevated D-Dimer level caused by tissue injury is believed to show a trendfor gradual decrease to normal within the first three days after trauma. MATERIAL/METHODS: To study theeffect of tissue injury on D-Dimer levels, we conducted a prospective measurement of D-Dimer levels inseverely traumatized, high-risk patients for DVT or PE, starting within 24 hours after admission untildisposition of the patient or to a total of 14 days of hospitalization. Patients were observed clinicallyfor development of thromboembolic phenomena, and were subjected to weekly surveillance using duplex scanof the lower extremities. Additional testing was done if requested by the attending trauma surgeon. RESULTS:A total of 21 patients were enrolled in the study. There were 17 males, and 4 females. Patients had amean age of (42) with a range of (17-79), and a mean ISS score of (20) with a range of (4-50). Sevenpatients completed 3-9 days of testing. Fourteen patients had more than 10 days of testing. Nine patientscompleted 14 days of testing. In all patients, tissue injury resulted in increased levels of D-Dimerabove a threshold (500 ng/ml), below which DVT or PE can be ruled out. The increased levels failed tonormalize even when testing was continued for 14 days. CONCLUSIONS: In our study, the increased D-Dimerlevels induced by tissue injury failed to show a trend of gradual return to normal within three daysafter trauma, as currently believed. This, in our opinion, may eliminate our ability to use D-Dimer testingto rule out DVT or PE in a subset of severely traumatized patients in the early post trauma period.
Keywords: Adolescent, Adult, Fibrin Fibrinogen Degradation Products, Pulmonary Embolism, Research Support, Non-U.S. Gov, Time Factors, Venous Thrombosis, Wounds and Injuries
This Week Editorial
20 September 2021 : EditorialEditorial: Autoantibodies to Components of the Immune System, Including Type 1 Interferons, and the Risk of Severe COVID-19
Med Sci Monit 2021; 27:e934766
22 September 2021 : EditorialEditorial: Global Regulatory Initiatives Deliver Accelerated Approval of the First Bispecific Therapeutic M...
Med Sci Monit In Press; DOI: 10.12659/MSM.934854
08 September 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit In Press; DOI: 10.12659/MSM.932788
16 July 2021 : Review articleSilent Hypoxemia in Patients with COVID-19 Pneumonia: A Review
Med Sci Monit In Press; DOI: 10.12659/MSM.930776
24 Sep 2021 : Clinical ResearchA Single-Center Study of a Resin Inlay Dental Implant-Fixed Prosthesis for Closing Proximal Contact Loss in...
Med Sci Monit In Press; DOI: 10.12659/MSM.933809
24 Sep 2021 : Database AnalysisRelationships Between Obstructive Sleep Apnea and Cardiovascular Disease: A Bibliometric Analysis (2010-2021)
Med Sci Monit In Press; DOI: 10.12659/MSM.933448
24 Sep 2021 : Database AnalysisA Statistical Prediction Model for Survival After Kidney Transplantation from Deceased Donors
Med Sci Monit In Press; DOI: 10.12659/MSM.933559
20 Mar 2020 : Clinical ResearchSocial Capital and Sleep Quality in Individuals Who Self-Isolated for 14 Days During the Coronavirus Diseas...
Med Sci Monit 2020; 26:e923921
15 Apr 2020 : Clinical ResearchPsychological Impact and Coping Strategies of Frontline Medical Staff in Hunan Between January and March 20...
Med Sci Monit 2020; 26:e924171
05 May 2020 : Review articleAn Evidence Based Perspective on mRNA-SARS-CoV-2 Vaccine Development
Med Sci Monit 2020; 26:e924700